| Pharmaceuticals Industry | Healthcare Sector | - CEO | HKEX Exchange | KYG2120E1290 ISIN |
| Hong Kong Country | 120 Employees | - Last Dividend | 25 Sep 2020 Last Split | - IPO Date |
China Healthwise Holdings Limited is a diversified investment holding company primarily engaged in the distribution of Chinese health products and pharmaceuticals across Hong Kong and The People's Republic of China. The company operates through three main segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. Originally operating under the name Haier Healthwise Holdings Limited, it rebranded in January 2017 to better reflect its focus on Chinese health and wellness products. Its headquarters are situated in Central, Hong Kong, from where it manages its operations and strategic direction focusing on tapping into the growing demand for traditional Chinese medicine and health products. Beyond its core retail business, China Healthwise Holdings Limited enhances its income streams through money lending services and making strategic investments in financial instruments, showcasing a diverse yet focused approach towards growth and sustainability in the health and wellness sector.
The company’s product offerings and services are diversified across various sectors within health and wellness, including: